Brown fat imaging with 18F-6-fluorodopamine PET/CT, 18F-FDG PET/CT, and 123I-MIBG SPECT: A study of patients being evaluated for pheochromocytoma

Journal of Nuclear Medicine

Volumn 48, Issue 7, 2007, Pages 1077-1083

  Hadi, Mohiuddin ^a   Chen, Clara C ^a   Whatley, Millie ^a   Pacak, Karel ^b   Carrasquillo, Jorge A ^a,c  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c NONE   (United States)

Author keywords

123I MIBG; 18F FDG; 18F fluorodopamine; Brown fat; PET; PET CT

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; 6 FLUORODOPAMINE; ADRENALIN; FLUORODEOXYGLUCOSE F 18; FLUORODOPAMINE F 18; NORADRENALIN; POTASSIUM IODIDE; TETROFOSMIN TC 99M; UNCLASSIFIED DRUG;

ADOLESCENT; ADRENALIN BLOOD LEVEL; ADRENERGIC NERVE; ADULT; AGED; ARTICLE; BROWN ADIPOSE TISSUE; COMPUTER ASSISTED TOMOGRAPHY; DRUG UPTAKE; FEMALE; HUMAN; MALE; NORADRENALIN BLOOD LEVEL; PHEOCHROMOCYTOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; RETROSPECTIVE STUDY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYMPATHETIC INNERVATION;

3-IODOBENZYLGUANIDINE; ADIPOSE TISSUE, BROWN; ADOLESCENT; ADRENAL GLAND NEOPLASMS; ADULT; AGED; AGED, 80 AND OVER; DOPAMINE; EPINEPHRINE; FEMALE; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; NOREPINEPHRINE; PHEOCHROMOCYTOMA; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SYMPATHETIC NERVOUS SYSTEM; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 34447315786     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.106.035915     Document Type: Article

References (38)

1. Hany TF, Gharehpapagh E, Kamel EM, Buck A, Himms-Hagen J, von Schulthess GK. Brown adipose tissue: a factor to consider in symmetrical tracer uptake in the neck and upper chest region. Eur J Nucl Med Mol Imaging. 2002;29:1393-1398.
2. Truong MT, Erasmus JJ, Munden RF, et al. Focal FDG uptake in mediastinal brown fat mimicking malignancy: a potential pitfall resolved on PET/CT. AJR. 2004;183:1127-1132.
3. 18F-FDG PET/CT. J Nucl Med. 2003;44:170-176.
4. 18F-FDG uptake in adipose tissue and muscle: a potential source of false-positives for PET. J Nucl Med. 2003;44:1789-1796.
5. 99mTc- tetrofosmin in pediatric patients. J Nucl Med. 2003;44:1582-1585.
6. 125I-metaiodobenzylguanidine visualization of brown adipose tissue. J Nucl Med. 2002;43:1234-1240.
7. 123I- Metaiodobenzylguanidine uptake in the nape of the neck of children: likely visualization of brown adipose tissue. J Nucl Med. 2003;44:1421-1425.
8. Cannon B, Nedergaard J. Brown adipose tissue: function and physiological significance. Physiol Rev. 2004;84:277-359.
9. Inokuma K, Okamatsu-Ogura Y, Omachi A, et al. Indispensable role of mitochondrial UCP1 for antiobesity effect of beta3-adrenergic stimulation. Am J Physiol Endocrinol Metab. 2006;290:E1014-E1021.
10. Arch JR, Ainsworth AT, Cawthorne MA, et al. Atypical beta-adrenoceptor on brown adipocytes as target for anti-obesity drugs. Nature. 1984;309:163-165.
11. Arch JR, Ainsworth AT, Ellis RD, et al. Treatment of obesity with thermogenic beta-adrenoceptor agonists: studies on BRL 26830A in rodents. Int J Obes. 1984;8(suppl 1):1-11.
12. Nedergaard J, Petrovic N, Lindgren EM, Jacobsson A, Cannon B. PPARgamma in the control of brown adipocyte differentiation. Biochim Biophys Acta. 2005; 1740:293-304.
13. Avram AS, Avram MM, James WD. Subcutaneous fat in normal and diseased states: 2. Anatomy and physiology of white and brown adipose tissue. J Am Acad Dermatol. 2005;53:671-683.
14. Valverde AM, Benito M, Lorenzo M. The brown adipose cell: a model for understanding the molecular mechanisms of insulin resistance. Acta Physiol Scand. 2005;183:59-73.
15. English JT, Patel SK, Flanagan MJ. Association of pheochromocytomas with brown fat tumors. Radiology. 1973;107:279-281.
16. Ricquier D, Nechad M, Mory G. Ultrastructural and biochemical characterization of human brown adipose tissue in pheochromocytoma. J Clin Endocrinol Metab. 1982;54:803-807.
17. Melicow MM. Hibernating fat and pheochromocytoma. AMA Arch Pathol. 1957;63:367-372.
18. Lean ME, James WP, Jennings G, Trayhurn P. Brown adipose tissue in patients with phaeochromocytoma. Int J Obes. 1986;10:219-227.
19. Goldstein DS, Chang PC, Eisenhofer G, et al. Positron emission tomographic imaging of cardiac sympathetic innervation and function. Circulation. 1990;81: 1606-1621.
20. 18F]fluorodopamine positron emission tomographic (PET) scanning for diagnostic localization of pheochromocytoma. Hypertension. 2001;38:6-8.
21. James W. Research on Obesity. London, U.K.: Her Majesty's Stationery Office; 1976.
22. Heaton JM. The distribution of brown adipose tissue in the human. J Anat. 1972;112:35-39.
23. 18F-FDG PET/CT. J Nucl Med. 2003;44:1267-1270.
24. 123I-MIBG uptake in the neck and shoulders of a neuroblastoma patient: damage to sympathetic innervation blocks uptake in brown adipose tissue. Pediatr Radiol. 2004;34:577-579.
25. Tatsumi M, Engles JM, Ishimori T, Nicely O, Cohade C, Wahl RL. Intense (18)F-FDG uptake in brown fat can be reduced pharmacologically. J Nucl Med. 2004;45:1189-1193.
26. Sundin U, Nechad M. Trophic response of rat brown fat by glucose feeding: involvement of sympathetic nervous system. Am J Physiol. 1983;244:C142-C149.
27. Ramacciotti C, Schneegans O, Lang H, et al. Diffuse uptake of brown fat on computed-tomography coupled positron emission tomoscintigraphy (PET-CT) for the exploration of extra-adrenal pheochromocytoma [in French]. Ann Endocrinol (Paris). 2006;67:14-19.
28. Fukuchi K, Tatsumi M, Ishida Y, Oku N, Hatazawa J, Wahl RL. Radionuclide imaging metabolic activity of brown adipose tissue in a patient with pheochromocytoma. Exp Clin Endocrinol Diabetes. 2004;112:601-603.
29. Goldstein DS, Coronado L, Kopin IJ. 6-[Fluorine-18]fluorodopamine pharmacokinetics and dosimetry in humans. J Nucl Med. 1994;35:964-973.
30. 18F] fluorodopamine: initial findings in humans. J Am Coll Cardiol. 1993;22:1961-1971.
31. Eisenhofer G, Hovevey-Sion D, Kopin IJ, et al. Neuronal uptake and metabolism of 2- and 6-fluorodopamine: false neurotransmitters for positron emission tomographic imaging of sympathetically innervated tissues. J Pharmacol Exp Ther. 1989;248:419-427.
32. 18F]fluorodeoxyglucose in the neck and upper chest region: are there predictive characteristics? Nucl Med Commun. 2004;25:1109-1111.
33. Shimizu Y, Nikami H, Saito M. Sympathetic activation of glucose utilization in brown adipose tissue in rats. J Biochem (Tokyo). 1991;110:688-692.
34. Chernogubova E, Cannon B, Bengtsson T. Norepinephrine increases glucose transport in brown adipocytes via beta3-adrenoceptors through a cAMP, PKA. and PI3-kinase-dependent pathway stimulating conventional and novel PKCs. Endocrinology. 2004;145:269-280.
35. Eldadah BA, Pacak K, Eisenhofer G, Holmes C, Kopin U, Goldstein DS. Cardiac uptake-1 inhibition by high circulating norepinephrine levels in patients with pheochromocytoma. Hypertension. 2004;43:1227-1232.
36. Agostini D, Darlas Y, Filmont JE, et al. The reversibility of cardiac neuronal function after removal of a pheochromocytoma: an 1-123 MIBG scintigraphic study. Clin Nucl Med. 1999;24:514-518.
37. Garcia CA, Van Nostrand D, Atkins F, et al. Reduction of brown fat 2-deoxy-2-[F-18]fluoro-D-glucose uptake by controlling environmental temperature prior to positron emission tomography scan. Mol Imaging Biol. 2006;8:24-29.
38. 18F]FDG) and PET in combination with microdialysis. Diabeiologia. 2001;44:2171-2179.